Company / Accounts Receivable
CONMED Corporation Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$247.8M
FY2025
5-year range
$183.9M / $247.8M
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#65 of 137
Health Care
What the data says
At $248M, CONMED Corporation's accounts receivable ranks #65 of 137 in the Health Care sector. Accounts Receivable has fluctuated over the past 10 years, ranging from $148M in FY2016 to $248M in FY2025.
Based on SEC 10-K filings.
$248M in FY2025 with a 5-year CAGR of +6.9%.
Improved from $242M to $248M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +9.0%
- 5-Year CAGR
- +6.9%
- 10-Year CAGR
- -
Sector benchmark
#65 of 137 in Health CareTop 47% of 137This company $247.8M Sector average $1.3B
▼
-81.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.9%, indicating consistent growth.
- In FY2025, accounts receivable increased 4.2% year-over-year.
- Ranks #65 out of 137 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $247.8M | +4.2% |
| FY2024 | $237.7M | -1.9% |
| FY2023 | $242.3M | +26.6% |
| FY2022 | $191.3M | +4.1% |
| FY2021 | $183.9M | +3.8% |
| FY2020 | $177.2M | -6.3% |
| FY2019 | $189.1M | +4.2% |
| FY2018 | $181.6M | +8.7% |
| FY2017 | $167.0M | +12.7% |
| FY2016 | $148.2M | +10.7% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026